The two groups did not show significant differences in postoperative hypertension, deep vein thrombosis, pulmonary embolism, calf muscular venous thrombosis, septic or aseptic wound complications, 90-day readmission, or albumin use (Table 5). The gene discussed is ALB; the disease is pulmonary embolism.